Athersys to Host Business Update Conference Call on April 20th

CLEVELAND--(BUSINESS WIRE)--Athersys, Inc. (NASDAQ: ATHX), a cell therapy and regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, announced today it will host a business update conference call on April 20, 2023 at 11:00 a.m. Eastern Time. Dan Camardo, Chief Executive Of...

Related Keywords

Ellen Gurley ,Dan Camardo ,Maia Hansen ,Willie Mays ,Kasey Rosado ,Nasdaq ,Twitter ,Athersys Inc ,Corporate Communications ,Linkedin ,Facebook ,Chief Executive Officer ,Chief Operating Officer ,Interim Chief Financial Officer ,Executive Vice President ,Regenerative Medicine ,Eastern Time ,Private Securities Litigation Reform Act ,